We inform you that the reference preparation Combivir® in the form of a tablet, film-coated tablets,300 mg + 150 mg updated information in the instructions for use (sections "Pharmacological properties", "Indications for use", "Contraindications", "Application during pregnancy and during breastfeeding", "Method of administration and dose", "Side effect" , "Overdose", Interaction with other medicinal products "," Special instructions "). This instruction is presented on the portal GRLS (03.08.17).
In connection with the foregoing, we consider it advisable to give instructions on the use of medicinal products, the active substances of which are zidovudine + 3TC in the form of medicine - film-coated tablets, 300 mg + 150 mg in accordance with the current information on the clinical experience of the clinical use of zidovudine + lamivudine.
Complete instructions for the use of the drug Combivir® is here.